A look into Opko Health Inc (OPK)’s deeper side

Opko Health Inc (NASDAQ: OPK) stock jumped 3.50% on Monday to $1.48 against a previous-day closing price of $1.43. With 2.99 million shares changed hands, the volume of the stock remained heavier than its average volume of 2.1 million shares. During the session, the Diagnostics & Research company that operates in wider Healthcare sector, reached to the highest price of $1.5000 whereas the lowest price it dropped to was $1.4200. The 52-week range on OPK shows that it touched its highest point at $2.24 and its lowest point at $1.00 during that stretch. It currently has a 1-year price target of $4.42. Beta for the stock currently stands at 1.84.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of OPK was up-trending over the past week, with a rise of 15.62%, but this was up by 14.73% over a month. Three-month performance dropped to -12.94% while six-month performance fell -1.33%. The stock lost -9.20% in the past year, while it has gained 18.40% so far this year. A look at the trailing 12-month EPS for OPK yields -0.28 with Next year EPS estimates of -0.22. For the next quarter, that number is -0.10. This implies an EPS growth rate of 43.48% for this year and 15.38% for next year. EPS is expected to grow by 12.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 3.51%.

Float and Shares Shorts:

At present, 772.65 million OPK shares are outstanding with a float of 414.71 million shares on hand for trading. On Oct 30, 2023, short shares totaled 29.92 million, which was 3.87% higher than short shares on Sep 28, 2023. In addition to Dr. Phillip Frost Ph.D. as the firm’s Chairman & CEO, Dr. Jane H. Hsiao M.B.A., Ph.D. serves as its Vice Chairman & Chief Technical Officer.

Institutional Ownership:

Through their ownership of 23.82% of OPK’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 6.89% of OPK, in contrast to 48.90% held by mutual funds. Shares owned by individuals account for 17.59%. As the largest shareholder in OPK with 4.99% of the stake, The Vanguard Group, Inc. holds 38,584,986 shares worth 38,584,986. A second-largest stockholder of OPK, BlackRock Fund Advisors, holds 29,683,350 shares, controlling over 3.84% of the firm’s shares. KSM Mutual Funds Ltd. is the third largest shareholder in OPK, holding 10,055,027 shares or 1.30% stake. With a 1.65% stake in OPK, the Vanguard Total Stock Market ETF is the largest stakeholder. A total of 12,728,537 shares are owned by the mutual fund manager. The Vanguard Small Cap Index Fund, which owns about 1.29% of OPK stock, is the second-largest Mutual Fund holder. It holds 9,933,158 shares valued at 12.42 million. iShares Russell 2000 ETF holds 1.22% of the stake in OPK, owning 9,459,063 shares worth 11.82 million.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for OPK since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With OPK analysts setting a high price target of $8.50 and a low target of $2.00, the average target price over the next 12 months is $4.42. Based on these targets, OPK could surge 474.32% to reach the target high and rise by 35.14% to reach the target low. Reaching the average price target will result in a growth of 198.65% from current levels.

Summary of Insider Activity:

Insiders traded OPK stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 84 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 2,885,245 while 0 shares were sold.